{"name":"Zevra Therapeutics","slug":"zevra-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":10161000,"netIncome":83229000,"cash":62406000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2015"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxQRTlkdC1URUIzRDkybkJiM1AyM0xneDVHWmloQ2JDNUh1LXc4NU9iM09IUTBFN1I0WGlfVWdKYVozM3FFX2VlWlN0Y1dVN0FGdGo3c0NRS1p2d3NJN1ZqT1hvUXppMmJZeHpJdWFJUXdFRUcwelhnZzhyZ0xzcTBzcVpIZHZSTXVQQUw3a1k0Z2UwckVfcWszOThyYXBPQ3VHczltWEZGMldFMmxqSVFyUUV5NjdOZmFFdjllSzMwYTlNN1ROdG40b1NTS1c3aTVDT3g0ckk0QnliVnJQUF95dlFORHp6cmd4U3RHN3NKTFhvUUU5dWtnWF91THNGMkd4V1ZPQ1RTc2MtUDFLQzNQVGF6ajJmWnhWSTA2b1hOSjVBZkNyb3VsN0ZIY2VZc3Bu?oc=5","date":"2026-03-12","type":"pipeline","source":"The Globe and Mail","summary":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR) - The Globe and Mail","headline":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and B","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-11","type":"earnings","source":"simplywall.st","summary":"Zevra Therapeutics (ZVRA) Profit Swing To US$77.6m TTM Tests Rare Disease Bull Case - simplywall.st","headline":"Zevra Therapeutics (ZVRA) Profit Swing To US$77.6m TTM Tests Rare Disease Bull Case","sentiment":"neutral"},{"date":"2026-03-09","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPY3ZpWDhCVUVnYnlXdGxpb2JYTjE5QnV2UlJGUEp5bXhXT24xUE95QnIwakdMQXU5Z3g3REs1bGVtTVJzUjQzbGZrM3dQWlpPeVdzeVZLZG9lSHdoVmQxYVpfd3l3ME42S3l1Ri1XRVp6UmFnTHlDQlh6Wkd1QkItcG04UmpxcXFHU0k1QWtRd3JrVWpvaXBYMVJnY2dOb1ZOcnJiYkdwTWY?oc=5","date":"2026-03-05","type":"pipeline","source":"citybiz","summary":"Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer - citybiz","headline":"Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNYWhCRll0TTNXV3l3OWpfZndCR2FVRlJneS02eUpGMURjRWVDeXNNMHJWWU9uWjVZakZRU0dDODBKWFl6Y2UxR0JqdnU3VDJXeGxOcG9TWUIyWUlHSDdMQkMtd2hXeTZyWDJDekJ0bW41WHctNkk2QU51eVRJdW1vYUdFR0tMUFFlV24xZkdHYy10NDVJTUlwNTZycDE3SGhCVlp0NVNrVHJVbHNSekRaU05xQ2hIR1FidmdwOWtRVDczUUZ5alZZX1lUYXJUTWZQZEw5VVM1T0VoTlJvNXc1bmtldmc?oc=5","date":"2026-03-05","type":"pipeline","source":"The Globe and Mail","summary":"Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer - The Globe and Mail","headline":"Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVjA5ZWJjdGp2SlllLWpPWXlOQk5DNU9ZVW9Kd0htYlpxS1VWQV9sazI0eTFiZGZ3d3BRME9TMmRnMnJEcDVZd3g4UmZYVTl1OFdpdlZIZmxNLW0tV3ZLMEp0N2pidi1GWmViNENHVlkyb2lsWFdGMXlpaHZYd05Hb0RhQnZCRmlORjk2YUNRU01BbEJNc0xnSm1MWHJDN0VDZFNIS1IyVmxXd3VnZVRxUXFjVWt5Q3RoT0xqcDJONmktNmlZenhCdGNKRl9UR1pJdTdELUl0QXozUQ?oc=5","date":"2025-12-02","type":"pipeline","source":"Quiver Quantitative","summary":"Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors, Announces Retirement of Wendy Dixon - Quiver Quantitative","headline":"Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors, Announces Retirement of Wendy Dixon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNYWJEVmxKUW5NNzFlcF8tMzdET3pOUUpDUUJPVUd0M3kwMEx1Z0h1WHdKbGluYjN2SHN0SjRDZG5xTVllVjltUlBHMjZkbEYzYWxhM1VoZTU4Z0dYeUJVRTV6UEpoQVlnM0FiVlV6ZndRTHhtT3JubFAtdm9nU3FLcWVQaHBqNWxBRFNKOXhvUVBVQQ?oc=5","date":"2025-12-02","type":"pipeline","source":"citybiz","summary":"Zevra Therapeutics Appoints Alicia Secor To Board - citybiz","headline":"Zevra Therapeutics Appoints Alicia Secor To Board","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-08","type":"pipeline","source":"simplywall.st","summary":"Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st","headline":"Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Just Reported And Analysts Have Been Cutting Their Estimates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQNzByN21YTXA1SzJqY3JEOWwwS1pIYWVncmcwekxqcGRSODRfSmp2SzlzWjJGWVI5RWtLMHFqNy1qWjdIVDB6NmJqVTlyQ2dqMXhtZ1dtUFlweFB6bWxEWGtiV0Jwd25YbndoY0xiczhDb1psWEpSNDJDUVgwNjVyODV3c1h2aFA4MC1ZZkEwLU96c0hfMzlFWHBZcXhlckN1QXQ3LUd0UFkzbDlEZ0tSOVd1SlNCS1pkSXR4a1N2anlzelhRUkVmQWZJZl90bTdWVzNmd2trWE5CdE5PRzhoNlRWVG8xRTDSAewBQVVfeXFMUHJjYzZ2S1BWaUg1OXV5TGFzdEFOUm0tVzJtUmtnOUdzUUVRSUhpazh4RjRaTXg1RjA5QXhWWmRPYkNYWEpCRl9GLUpONDRzaFliQUozeEhEbG5IZFdjVGlfcWUySXV3STZ5LUhrUFNmc0FNT0pDQTluUHJ3czN6Rk45cVlGaElKWndsSF9lVG9CVmFvZWhhNGktVGlOWGU1LUpGNnNFTlhXZ01uczlMVERGNDY2akNNQjNMQlEyMmV1eDdJTUZEaDBqbUJJcG56LUtUUlY3UFdZWl95UTRBUVp2TU16MENwNkZJbEg?oc=5","date":"2025-09-08","type":"pipeline","source":"simplywall.st","summary":"What You Can Learn From Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) P/S After Its 26% Share Price Crash - simplywall.st","headline":"What You Can Learn From Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) P/S After Its 26% Share Price Crash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQdVUtS1BWZHo3MUVENldqYmZrZVdHZmxVeWY0bjNxNDd1WENVLWppQ2xYejlYMWZ1OThoXzVnTmlsVXp2d3ROZVVXY1g5SXJIdTRpcnAyOHdKb1YteUdsRWxsY0ZuUFVMbjdPSjBGZm1fNW43SE1NOTVDUFRRSExENk5TUWoyTW1DRVhuZ0ZPSGVCYUVzeGZxeXh3Z2FuZ1lOT000N3E5RmtjWTJ4OW0w?oc=5","date":"2025-05-22","type":"regulatory","source":"Genetic Engineering and Biotechnology News","summary":"Zevra Cashes in on First FDA-Approved NPC Treatment with PRV - Genetic Engineering and Biotechnology News","headline":"Zevra Cashes in on First FDA-Approved NPC Treatment with PRV","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5DaHg2X1pNN3VIaGc3bzNTTjRMZHYwcmh0dmk4SzdDY1pDeXB1dmRoVkg0Qmg4Vk45azB5R0VTRjk5WVJKTEg1ZExuVkxXdlZLdWxr?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"ZVRA Stock Price, News & Analysis - Stock Titan","headline":"ZVRA Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQQllydTZ1VGhrR1M2VzFoU1YxSlpKNVh3cksxZVhRdjQxeXV0dHNBcWF0MDAyNmRyY1MteGNPcmJRcGhpOUgyZVNydVhGanYza0JlcURvNkgya0NRMFI4RGNYc3E2X3pPZGhmallHVjFiU0ZGd1Npa2V1WTQtMkV5ZndnWVdORmRCdUlCOVJMREJQc0xVVktBVERrbWdrZEczWDNhQTF0Q0RrNGU5dEduaFhmVmN5ZnVvRGp2aQ?oc=5","date":"2025-03-13","type":"pipeline","source":"Fierce Pharma","summary":"Zevra Therapeutics embarks on diagnosis push as Miplyffa launch gains steam - Fierce Pharma","headline":"Zevra Therapeutics embarks on diagnosis push as Miplyffa launch gains steam","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPaS05eHpqWXVLWWVWNGJnQmlURVF2TDBFdF9aRVFfcmhyOEJmTW1GdU91ZUJnWWc5d2JpNXpicEpWQTVlOTJhZ3h3cHF3Qnh1VmhjT0dSNWhpdHJrN0kyRWx0eU9SbUNSNUJsb1JPdm5uQjVGeDNCRWkyTE5KNjVqWi1mcHBYSHlTRWJEcWsxSEhhdjJWNnhweDRRLUZyenl3aHg3QjFHSkk4alFTQk5CZDAwSkNMUQ?oc=5","date":"2025-02-27","type":"regulatory","source":"MedCity News","summary":"Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M - MedCity News","headline":"Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2015-12-31","revenueHistory":[{"value":0,"period":"2015-12-31"},{"value":0,"period":"2015-09-30"},{"value":0,"period":"2015-06-30"},{"value":0,"period":"2015-03-31"},{"value":0,"period":"2014-12-31"},{"value":0,"period":"2014-09-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":10161000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":83229000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":62406000,"cashHistory":[],"totalAssets":284731000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}